Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
2010 StandoutScience
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
2015 StandoutScience
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
2016
Immunomodulatory properties of mesenchymal stromal cells
2007 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Immunological aspects of cancer chemotherapy
2007
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
2015
Immunotherapy of cancer in 2012
2012
Systematic Analysis of Reportedly Distinct Populations of Multipotent Bone Marrow-Derived Stem Cells Reveals a Lack of Distinction
2002
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
2006 StandoutNature
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
2008
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Dynamics of fat cell turnover in humans
2008 StandoutNature
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
Bone marrow cells regenerate infarcted myocardium
2001 StandoutNature
In Vitro Differentiation of Human Marrow Stromal Cells into Early Progenitors of Neural Cells by Conditions That Increase Intracellular Cyclic AMP
2001
Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: Disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype
2004
Cardiac Stem Cells and Mechanisms of Myocardial Regeneration
2005
Changing potency by spontaneous fusion
2002 StandoutNature
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts
2004 StandoutNature
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
The Evolving Concept of a Stem Cell
2001
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy
2011
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Stem cell biology of the central nervous system
2002
Human cortical glial tumors contain neural stem‐like cells expressing astroglial and neuronal markers in vitro
2002
In Vitro Differentiation of Human Processed Lipoaspirate Cells into Early Neural Progenitors
2003
Immunity, Inflammation, and Cancer
2010 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Stem cells, ageing and the quest for immortality
2006 StandoutNature
Novel approaches in the therapy of metastatic renal cell carcinoma
2005
Astrocytic and neuronal fate of mesenchymal stem cells expressing nestin
2005
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
2010
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Immunization with a P53 synthetic long peptide vaccine induces P53‐specific immune responses in ovarian cancer patients, a phase II trial
2009
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
2004
Cancer immunotherapy comes of age
2011 StandoutNature
Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis
2002
The human adipose tissue is a source of multipotent stem cells
2004
Therapeutic vaccines for cancer: an overview of clinical trials
2014
Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord
2003
Split T Cell Tolerance against a Self/Tumor Antigen: Spontaneous CD4+ but Not CD8+ T Cell Responses against p53 in Cancer Patients and Healthy Donors
2011
Comparison of Multi-Lineage Cells from Human Adipose Tissue and Bone Marrow
2003
Identification of human brain tumour initiating cells
2004 StandoutNature
History of myeloid-derived suppressor cells
2013
Cancer-related inflammation
2008 StandoutNature
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Matrix Elasticity Directs Stem Cell Lineage Specification
2006 Standout
Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion
2002 StandoutNature
Lymphatic Mapping and Sentinel Node Biopsy in the Patient With Breast Cancer
1996 Standout
Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery
2002
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Selective Differentiation of Neural Progenitor Cells by High-Epitope Density Nanofibers
2004 StandoutScience
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
2007 StandoutNobel
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Differential Requirement for CD70 and CD80/CD86 in Dendritic Cell-Mediated Activation of Tumor-Tolerized CD8 T Cells
2012
TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis
2006
Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.
2003
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Bone Marrow-Derived Cells that Populate the Adult Mouse Brain Preserve Their Hematopoietic Identity
2003
Mesenchymal Stem Cells Spontaneously Express Neural Proteins in Culture and Are Neurogenic after Transplantation
2005
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Human Adipose Tissue Is a Source of Multipotent Stem Cells
2002 Standout
Cancer Genome Landscapes
2013 StandoutScience
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
2008
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
Grafted human-induced pluripotent stem-cell–derived neurospheres promote motor functional recovery after spinal cord injury in mice
2011 StandoutNobel
Neoantigens in cancer immunotherapy
2015 StandoutScience
Turning Blood into Brain: Cells Bearing Neuronal Antigens Generated in Vivo from Bone Marrow
2000 Science
IL-2: The First Effective Immunotherapy for Human Cancer
2014
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
2012
Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma
2013
Works of William E. Janssen being referenced
Combination of External Beam Radiotherapy (EBRT) With Intratumoral Injection of Dendritic Cells as Neo-Adjuvant Treatment of High-Risk Soft Tissue Sarcoma Patients
2011
High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study.
1991
Efficacy of Adoptive Cell Transfer of Tumor-infiltrating Lymphocytes After Lymphopenia Induction for Metastatic Melanoma
2012
Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation
2003
Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation.
1996
Adult Bone Marrow Stromal Cells Differentiate into Neural Cells in Vitro
2000
Combination of p53 Cancer Vaccine with Chemotherapy in Patients with Extensive Stage Small Cell Lung Cancer
2006
A phase i study of high-dose melphalan + topotecan + VP-16 phosphate (Mtv) Followed by autologous stem cell rescue in multiple myeloma
2000
Pre-Transplant 5-Azacitidine (Vidaza®) May Improve Outcome of Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Myelodysplastic Syndrome (MDS).
2006
An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism.
2001
Phase I Trial of a B7-1 (CD80) Gene Modified Autologous Tumor Cell Vaccine in Combination With Systemic Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma
2002